|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the possession and administration of an opioid |
|
antagonist by certain entities. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Subchapter A, Chapter 773, Health and Safety |
|
Code, is amended by adding Section 773.018 to read as follows: |
|
Sec. 773.018. POSSESSION AND ADMINISTRATION OF OPIOID |
|
ANTAGONIST. (a) In this section, "live music venue" means a |
|
business with a space for live music and a primary revenue source of |
|
patron attendance to live music performances. The term includes a |
|
concert hall and indoor or outdoor stadium. |
|
(b) This section applies to: |
|
(1) an amusement park, as defined by Section 46.03, |
|
Penal Code; |
|
(2) a live music venue; |
|
(3) a sports venue, as defined by Section 504.151, |
|
Local Government Code; and |
|
(4) subject to Subsection (c), other entities the |
|
executive commissioner by rule designates as an entity that |
|
benefits from the possession and administration of opioid |
|
antagonists. |
|
(c) This section does not apply to a governmental entity. |
|
(d) An entity subject to this section may adopt a policy |
|
regarding the maintenance, administration, and disposal of opioid |
|
antagonists. The policy must authorize the administration of an |
|
opioid antagonist for a person reasonably believed to be |
|
experiencing an opioid overdose on the entity's premises only by an |
|
entity employee or volunteer who is authorized and trained to |
|
administer the opioid antagonist. |
|
(e) The executive commissioner shall adopt rules regarding |
|
an entity's maintenance, administration, and disposal of opioid |
|
antagonists under this section. The rules must establish: |
|
(1) the number and dosages of the opioid antagonists |
|
available at each entity; |
|
(2) the process for each entity to regularly verify |
|
its inventory of opioid antagonists for replacement of expired |
|
opioid antagonists; and |
|
(3) the training required for an entity employee or |
|
volunteer to administer an opioid antagonist. |
|
(f) Each entity that adopts a policy under Subsection (d) |
|
must have at least one entity employee or volunteer authorized and |
|
trained to administer an opioid antagonist present during all hours |
|
the entity is open to the public or the population the entity |
|
serves, as applicable. |
|
(g) The entity's supply of opioid antagonists must: |
|
(1) be stored in a secure location and in accordance |
|
with the manufacturer's instructions; and |
|
(2) be easily accessible to an entity employee or |
|
volunteer who is authorized and trained to administer an opioid |
|
antagonist. |
|
(h) Each entity that adopts a policy under Subsection (d) is |
|
responsible for training the entity's employees and volunteers in |
|
the administration of an opioid antagonist. The training must: |
|
(1) include information on: |
|
(A) the signs and symptoms of an opioid overdose; |
|
(B) the recommended opioid antagonist dosages |
|
for an adult and a child; |
|
(C) the administration of an opioid antagonist; |
|
(D) the implementation of any necessary |
|
emergency procedures after administration of an opioid antagonist; |
|
and |
|
(E) the proper disposal of a used or expired |
|
opioid antagonist; and |
|
(2) be completed annually in a formal training session |
|
or through online education. |
|
(i) Each entity shall maintain records on the training |
|
completed by each entity employee and volunteer under this section. |
|
(j) An entity, entity employee or volunteer, or other person |
|
who in good faith acts or fails to act as authorized under this |
|
section, including by administering an opioid antagonist as |
|
authorized in a policy adopted under this section, is immune from |
|
civil or criminal liability or disciplinary action resulting from |
|
that act or failure to act, including: |
|
(1) supervising or delegating the administration of an |
|
opioid antagonist; |
|
(2) possessing, maintaining, storing, or disposing of |
|
an opioid antagonist; |
|
(3) administering, or assisting in the administration |
|
of, an opioid antagonist; |
|
(4) providing training, consultation, or advice in the |
|
development, adoption, or implementation of policies, guidelines, |
|
or plans; or |
|
(5) any other act authorized or required under this |
|
section. |
|
(k) The immunities and protections provided by this section |
|
are in addition to other immunities or limitations of liability |
|
provided by law. |
|
(l) Notwithstanding any other law, this section does not |
|
create a civil, criminal, or administrative cause of action or |
|
liability or create a standard of care, obligation, or duty that |
|
provides a basis for a cause of action for an act or omission under |
|
this section. A cause of action does not arise from an act or |
|
omission described by this section. |
|
(m) An act or failure to act by an entity employee or |
|
volunteer under this section, including an act or failure to act |
|
under related entity policies and procedures, is the exercise of |
|
judgment or discretion on the part of the entity employee or |
|
volunteer and is not considered to be a ministerial act for purposes |
|
of liability of the entity. |
|
SECTION 2. This Act takes effect September 1, 2025. |